ZCCHC4
gene geneOn this page
Also known as HSPC052FLJ23024ZGRF4
Summary
ZCCHC4 (zinc finger CCHC-type containing 4, HGNC:22917) is a protein-coding gene on chromosome 4p15.2, encoding rRNA N(6)-adenosine-methyltransferase ZCCHC4 (Q9H5U6). rRNA N6-methyltransferase that specifically methylates the adenine in position 4220 of 28S rRNA.
Enables S-adenosyl-L-methionine binding activity; rRNA (adenine-N6-)-methyltransferase activity; and zinc ion binding activity. Involved in positive regulation of translation and rRNA methylation. Located in cytoplasm and nucleolus.
Source: NCBI Gene 29063 — RefSeq curated summary.
At a glance
- GWAS associations: 4
- Clinical variants (ClinVar): 109 total
- MANE Select transcript:
NM_024936
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:22917 |
| Approved symbol | ZCCHC4 |
| Name | zinc finger CCHC-type containing 4 |
| Location | 4p15.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | HSPC052, FLJ23024, ZGRF4 |
| Ensembl gene | ENSG00000168228 |
| Ensembl biotype | protein_coding |
| OMIM | 611792 |
| Entrez | 29063 |
Gene structure
Transcript identifiers
Ensembl transcripts: 8 — 5 protein_coding, 1 protein_coding_CDS_not_defined, 1 nonsense_mediated_decay, 1 retained_intron
ENST00000302874, ENST00000505412, ENST00000505451, ENST00000507760, ENST00000508058, ENST00000904257, ENST00000931732, ENST00000931733
RefSeq mRNA: 2 — MANE Select: NM_024936
NM_001318148, NM_024936
CCDS: CCDS43218
Canonical transcript exons
ENST00000302874 — 13 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001766877 | 25365022 | 25365166 |
| ENSE00001767779 | 25369029 | 25370383 |
| ENSE00002040802 | 25312774 | 25312936 |
| ENSE00003468245 | 25364454 | 25364505 |
| ENSE00003501870 | 25349492 | 25349642 |
| ENSE00003550497 | 25362226 | 25362301 |
| ENSE00003571386 | 25315318 | 25315400 |
| ENSE00003608316 | 25333908 | 25333988 |
| ENSE00003614966 | 25361859 | 25361980 |
| ENSE00003655007 | 25314046 | 25314164 |
| ENSE00003665658 | 25345548 | 25345620 |
| ENSE00003669231 | 25351589 | 25351689 |
| ENSE00003682837 | 25333183 | 25333458 |
Expression profiles
Bgee: expression breadth ubiquitous, 181 present calls, max score 83.92.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 7.9900 / max 110.0044, expressed in 1771 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 47128 | 7.9900 | 1771 |
Top tissues by expression
284 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 83.92 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 83.20 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 82.55 | gold quality |
| gastrocnemius | UBERON:0001388 | 80.43 | gold quality |
| calcaneal tendon | UBERON:0003701 | 80.34 | gold quality |
| muscle of leg | UBERON:0001383 | 80.28 | gold quality |
| ventricular zone | UBERON:0003053 | 80.05 | gold quality |
| stromal cell of endometrium | CL:0002255 | 79.08 | gold quality |
| colonic epithelium | UBERON:0000397 | 78.64 | gold quality |
| body of uterus | UBERON:0009853 | 77.79 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 77.65 | gold quality |
| right adrenal gland | UBERON:0001233 | 77.32 | gold quality |
| left uterine tube | UBERON:0001303 | 77.26 | gold quality |
| apex of heart | UBERON:0002098 | 77.25 | gold quality |
| ganglionic eminence | UBERON:0004023 | 77.14 | gold quality |
| tibial nerve | UBERON:0001323 | 76.73 | gold quality |
| ectocervix | UBERON:0012249 | 76.66 | gold quality |
| left ovary | UBERON:0002119 | 76.54 | gold quality |
| left adrenal gland | UBERON:0001234 | 76.52 | gold quality |
| islet of Langerhans | UBERON:0000006 | 76.50 | gold quality |
| popliteal artery | UBERON:0002250 | 76.40 | gold quality |
| tibial artery | UBERON:0007610 | 76.40 | gold quality |
| right ovary | UBERON:0002118 | 76.33 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 76.16 | gold quality |
| rectum | UBERON:0001052 | 76.04 | gold quality |
| body of pancreas | UBERON:0001150 | 76.00 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 76.00 | gold quality |
| aorta | UBERON:0000947 | 75.90 | gold quality |
| metanephros cortex | UBERON:0010533 | 75.88 | gold quality |
| sural nerve | UBERON:0015488 | 75.86 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 4.71 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
41 targeting ZCCHC4, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-4692 | 100.00 | 67.32 | 2066 |
| HSA-MIR-5692A | 100.00 | 74.40 | 6850 |
| HSA-MIR-371B-5P | 99.99 | 75.34 | 4759 |
| HSA-MIR-4514 | 99.99 | 67.10 | 1870 |
| HSA-MIR-513B-5P | 99.99 | 69.96 | 2150 |
| HSA-MIR-373-5P | 99.98 | 75.36 | 4753 |
| HSA-MIR-616-5P | 99.98 | 75.58 | 4775 |
| HSA-MIR-520D-5P | 99.98 | 73.34 | 4883 |
| HSA-MIR-524-5P | 99.98 | 73.43 | 4882 |
| HSA-MIR-12136 | 99.98 | 72.81 | 5713 |
| HSA-MIR-9-3P | 99.96 | 70.88 | 2068 |
| HSA-MIR-141-3P | 99.94 | 72.79 | 2421 |
| HSA-MIR-200A-3P | 99.94 | 72.68 | 2420 |
| HSA-MIR-6835-3P | 99.93 | 70.49 | 2904 |
| HSA-MIR-335-3P | 99.93 | 73.36 | 4958 |
| HSA-MIR-4668-5P | 99.79 | 70.58 | 3782 |
| HSA-MIR-3617-5P | 99.75 | 69.41 | 1968 |
| HSA-MIR-641 | 99.75 | 69.35 | 1975 |
| HSA-MIR-6745 | 99.74 | 65.33 | 1321 |
| HSA-MIR-4422 | 99.72 | 72.07 | 2908 |
| HSA-MIR-3714 | 99.71 | 70.74 | 2671 |
| HSA-MIR-548AV-5P | 99.60 | 70.84 | 2107 |
| HSA-MIR-548K | 99.60 | 70.84 | 2107 |
| HSA-MIR-6740-3P | 99.48 | 68.49 | 1392 |
| HSA-MIR-363-5P | 99.46 | 64.51 | 1015 |
| HSA-MIR-372-5P | 99.41 | 69.11 | 2299 |
| HSA-MIR-892C-5P | 99.16 | 70.56 | 2116 |
| HSA-MIR-4796-3P | 99.08 | 68.38 | 1681 |
| HSA-MIR-4297 | 98.77 | 66.95 | 2013 |
Literature-anchored findings (GeneRIF, showing 6)
- ZCCHC4 protein is overexpressed in hepatocellular carcinoma tumors.ZCCHC4 is an m6A RNA methyltransferase. (PMID:30531910)
- 3.1 A-resolution crystal structure of human CCHC zinc finger-containing protein ZCCHC4, a 28S rRNA-specific m(6)A methyltransferase, bound to S-adenosyl-L-homocysteine. Mutational and enzymatic analyses further substantiate the molecular basis for ZCCHC4-RNA recognition and a role of the stem-loop structure within substrate in governing the substrate specificity. (PMID:31695039)
- In summary, we establish ZCCHC4 as the enzyme responsible for m6A modification of human 28S rRNA, and demonstrate its functional significance in mRNA translation. (PMID:31799605)
- RNA-binding protein ZCCHC4 promotes human cancer chemoresistance by disrupting DNA-damage-induced apoptosis. (PMID:35853866)
- ZCCHC4 Promotes Osteosarcoma Progression by Upregulating ITGB1. (PMID:37606162)
- The epigenetic downregulation of LncGHRLOS mediated by RNA m6A methylase ZCCHC4 promotes colorectal cancer tumorigenesis. (PMID:38326863)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | zcchc4 | ENSDARG00000104531 |
| mus_musculus | Zcchc4 | ENSMUSG00000029179 |
| rattus_norvegicus | Zcchc4 | ENSRNOG00000029064 |
| drosophila_melanogaster | CG12863 | FBGN0033948 |
| caenorhabditis_elegans | WBGENE00009352 |
Protein
Protein identifiers
rRNA N(6)-adenosine-methyltransferase ZCCHC4 — Q9H5U6 (reviewed: Q9H5U6)
Alternative names: Zinc finger CCHC domain-containing protein 4
All UniProt accessions (2): Q9H5U6, H0Y8V8
UniProt curated annotations — full annotation on UniProt →
Function. rRNA N6-methyltransferase that specifically methylates the adenine in position 4220 of 28S rRNA. N6-methylation of adenine(4220) in 28S rRNA is required for translation.
Subunit / interactions. Interacts with components of the ASC-1 complex TRIP4, ASCC1, ASCC2 and ASCC3. Interact with AHCYL1 and AHCYL2. Interact with YTHDC2.
Subcellular location. Nucleus. Nucleolus. Cytoplasm.
Domain organisation. The regulatory loop blocks the catalytic center by bridging the methyltransferase domain and the C-terminal CCHC-type zinc finger, resulting in an autoinhibitory conformation.
Similarity. Belongs to the ZCCHC4 family.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q9H5U6-1 | 1 | yes |
| Q9H5U6-2 | 2 | |
| Q9H5U6-3 | 3 |
RefSeq proteins (1): NP_079212* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR002052 | DNA_methylase_N6_adenine_CS | Conserved_site |
| IPR010666 | Znf_GRF | Domain |
| IPR039846 | ZCCHC4 | Family |
| IPR041370 | Mlase_EEF1AKMT1/ZCCHC4 | Family |
Pfam: PF06839, PF10237
Catalyzed reactions (Rhea), 1 shown:
- adenosine(4220) in 28S rRNA + S-adenosyl-L-methionine = N(6)-methyladenosine(4220) in 28S rRNA + S-adenosyl-L-homocysteine + H(+) (RHEA:58724)
UniProt features (98 total): binding site 29, strand 20, helix 16, turn 10, mutagenesis site 9, compositionally biased region 3, zinc finger region 2, splice variant 2, region of interest 2, sequence variant 2, chain 1, domain 1, sequence conflict 1
Structure
Experimental structures (PDB)
1 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 6UCA | X-RAY DIFFRACTION | 3.1 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9H5U6-F1 | 83.14 | 0.64 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Ligand- & substrate-binding residues (29): 42; 64; 73; 125; 128; 140; 143; 172–175; 202; 225; 243–244; 276 …
Mutagenesis-validated functional residues (9):
| Position | Phenotype |
|---|---|
| 173 | abolished rrna methyltransferase activity. |
| 276–279 | loss of methyltransferase activity. |
| 276 | loss of methyltransferase activity. |
| 340 | strongly impaired rrna methyltransferase activity. |
| 341 | increased rrna methylation. |
| 342 | strongly impaired rrna methyltransferase activity. |
| 343 | decreased s-adenosyl-l-methionine-binding. |
| 343 | strongly impaired rrna methyltransferase activity. |
| 345 | increased rrna methylation. |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 139 (showing top):
GOBP_RIBOSOME_BIOGENESIS, WANG_CLIM2_TARGETS_UP, MODULE_255, MODULE_317, GOBP_RNA_METHYLATION, GOBP_TRANSLATION, GOBP_POST_TRANSCRIPTIONAL_REGULATION_OF_GENE_EXPRESSION, GOBP_RNA_MODIFICATION, MODULE_48, GOBP_RRNA_MODIFICATION, GOBP_METHYLATION, MODULE_95, GOBP_RIBONUCLEOPROTEIN_COMPLEX_BIOGENESIS, GOBP_RRNA_METHYLATION, GOBP_POSITIVE_REGULATION_OF_TRANSLATION
GO Biological Process (3): rRNA methylation (GO:0031167), positive regulation of translation (GO:0045727), methylation (GO:0032259)
GO Molecular Function (7): nucleic acid binding (GO:0003676), zinc ion binding (GO:0008270), rRNA (adenine-N6-)-methyltransferase activity (GO:0008988), S-adenosyl-L-methionine binding (GO:1904047), methyltransferase activity (GO:0008168), transferase activity (GO:0016740), metal ion binding (GO:0046872)
GO Cellular Component (3): nucleolus (GO:0005730), cytoplasm (GO:0005737), nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cation binding | 2 |
| rRNA modification | 1 |
| RNA methylation | 1 |
| translation | 1 |
| regulation of translation | 1 |
| positive regulation of gene expression | 1 |
| positive regulation of protein metabolic process | 1 |
| metabolic process | 1 |
| binding | 1 |
| transition metal ion binding | 1 |
| N-methyltransferase activity | 1 |
| rRNA (adenine) methyltransferase activity | 1 |
| sulfur compound binding | 1 |
| transferase activity, transferring one-carbon groups | 1 |
| catalytic activity | 1 |
| nuclear lumen | 1 |
| intracellular membraneless organelle | 1 |
| intracellular anatomical structure | 1 |
| cellular anatomical structure | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
1503 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZCCHC4 | METTL5 | Q9NRN9 | 969 |
| ZCCHC4 | LSM12 | Q3MHD2 | 952 |
| ZCCHC4 | ZC3H13 | Q5T200 | 946 |
| ZCCHC4 | METTL16 | Q86W50 | 946 |
| ZCCHC4 | METTL14 | Q9HCE5 | 874 |
| ZCCHC4 | VIRMA | Q69YN4 | 873 |
| ZCCHC4 | WTAP | Q15007 | 861 |
| ZCCHC4 | RBM15 | Q96T37 | 820 |
| ZCCHC4 | METTL3 | Q86U44 | 788 |
| ZCCHC4 | TRMT112 | Q9UI30 | 771 |
| ZCCHC4 | CBLL1 | Q75N03 | 630 |
| ZCCHC4 | ALKBH5 | Q6P6C2 | 626 |
| ZCCHC4 | RBM15B | Q8NDT2 | 621 |
| ZCCHC4 | YTHDC1 | Q96MU7 | 592 |
| ZCCHC4 | FTO | Q9C0B1 | 591 |
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ZCCHC4 | RPS6 | psi-mi:“MI:0915”(physical association) | 0.400 |
BioGRID (12): ZCCHC4 (Affinity Capture-MS), ZCCHC4 (Proximity Label-MS), ZCCHC4 (Affinity Capture-MS), ZCCHC4 (Affinity Capture-MS), ZCCHC4 (Affinity Capture-MS), ZCCHC4 (Affinity Capture-MS), ZCCHC4 (Affinity Capture-MS), ZCCHC4 (Affinity Capture-MS), ZCCHC4 (Affinity Capture-MS), ZCCHC4 (Affinity Capture-RNA), ZCCHC4 (Proximity Label-MS), ZCCHC4 (Affinity Capture-RNA)
ESM2 similar proteins: A0A1L1SUL6, F1LQY6, O35465, O43379, O75293, O88910, O88954, P0C0T1, P21964, P22339, P41214, P50747, Q13368, Q13572, Q14318, Q16342, Q1HAQ0, Q28955, Q2T9Z1, Q3B7U9, Q3TFD2, Q3TMX7, Q496Y0, Q4AC99, Q5BIM1, Q5E9A5, Q5R812, Q5RA63, Q5SZD4, Q64311, Q6DC64, Q6P5G6, Q6PFY8, Q80YV4, Q8BNV1, Q8BYN3, Q8NFZ0, Q8R1C6, Q8R1T1, Q8TCU6
Diamond homologs: D3ZV31, E1BGQ2, Q66IH9, Q6DCD7, Q8BKW4, Q9H5U6
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
109 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 79 |
| Likely benign | 5 |
| Benign | 5 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
2549 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 4:25314033:A:AG | acceptor_gain | 1.0000 |
| 4:25314033:ATTCT:A | acceptor_gain | 1.0000 |
| 4:25314034:T:G | acceptor_gain | 1.0000 |
| 4:25314037:T:TA | acceptor_gain | 1.0000 |
| 4:25314038:G:A | acceptor_gain | 1.0000 |
| 4:25315314:TCAGT:T | acceptor_loss | 1.0000 |
| 4:25315316:A:AG | acceptor_gain | 1.0000 |
| 4:25315317:G:GA | acceptor_gain | 1.0000 |
| 4:25315317:GT:G | acceptor_gain | 1.0000 |
| 4:25315317:GTT:G | acceptor_gain | 1.0000 |
| 4:25315397:AAAG:A | donor_loss | 1.0000 |
| 4:25315398:AAGGT:A | donor_loss | 1.0000 |
| 4:25315399:AGGT:A | donor_loss | 1.0000 |
| 4:25315400:GGTAC:G | donor_loss | 1.0000 |
| 4:25315401:G:GA | donor_loss | 1.0000 |
| 4:25315402:T:A | donor_loss | 1.0000 |
| 4:25333984:TTTCG:T | donor_loss | 1.0000 |
| 4:25333985:TTCG:T | donor_loss | 1.0000 |
| 4:25333987:CGG:C | donor_loss | 1.0000 |
| 4:25333988:GGT:G | donor_loss | 1.0000 |
| 4:25333989:G:GG | donor_gain | 1.0000 |
| 4:25333989:GTAGG:G | donor_loss | 1.0000 |
| 4:25333990:T:G | donor_loss | 1.0000 |
| 4:25349605:G:GT | donor_gain | 1.0000 |
| 4:25349609:T:G | donor_gain | 1.0000 |
| 4:25361858:GGTA:G | acceptor_gain | 1.0000 |
| 4:25364501:GCCTT:G | donor_gain | 1.0000 |
| 4:25365127:G:GG | donor_gain | 1.0000 |
| 4:25365167:G:GG | donor_gain | 1.0000 |
| 4:25312885:G:GT | donor_gain | 0.9900 |
AlphaMissense
3419 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 4:25349567:T:C | F279L | 0.998 |
| 4:25349569:T:A | F279L | 0.998 |
| 4:25349569:T:G | F279L | 0.998 |
| 4:25361922:C:A | R359S | 0.997 |
| 4:25361923:G:C | R359P | 0.997 |
| 4:25351618:T:A | W314R | 0.996 |
| 4:25351618:T:C | W314R | 0.996 |
| 4:25351633:T:C | F319L | 0.996 |
| 4:25351635:T:A | F319L | 0.996 |
| 4:25351635:T:G | F319L | 0.996 |
| 4:25361928:T:C | F361L | 0.996 |
| 4:25361930:C:A | F361L | 0.996 |
| 4:25361930:C:G | F361L | 0.996 |
| 4:25345590:T:A | N243K | 0.995 |
| 4:25345590:T:G | N243K | 0.995 |
| 4:25314108:T:C | C64R | 0.994 |
| 4:25314122:A:C | R68S | 0.994 |
| 4:25314122:A:T | R68S | 0.994 |
| 4:25349565:C:A | P278Q | 0.994 |
| 4:25351630:T:G | Y318D | 0.994 |
| 4:25361876:T:A | H343Q | 0.994 |
| 4:25361876:T:G | H343Q | 0.994 |
| 4:25362230:T:C | C380R | 0.994 |
| 4:25364501:G:C | K419N | 0.994 |
| 4:25364501:G:T | K419N | 0.994 |
| 4:25361865:T:C | Y340H | 0.993 |
| 4:25361874:C:G | H343D | 0.993 |
| 4:25361920:T:A | V358E | 0.993 |
| 4:25361929:T:C | F361S | 0.993 |
| 4:25314099:T:C | F61L | 0.992 |
dbSNP variants (sampled 300 via entrez): RS1000006328 (4:25321670 G>A), RS1000086427 (4:25343297 T>C), RS1000131705 (4:25328403 C>A), RS1000134812 (4:25314159 G>C,T), RS1000141684 (4:25357019 A>G), RS1000142344 (4:25346989 A>G), RS10001598 (4:25351449 T>C), RS10001797 (4:25323563 A>G), RS1000216876 (4:25332960 G>A,T), RS1000263162 (4:25356752 T>C,G), RS1000349100 (4:25362554 C>G,T), RS1000396824 (4:25340638 C>G), RS10004567 (4:25331229 C>G,T), RS1000505536 (4:25328152 G>A,T), RS1000540433 (4:25331464 C>G,T)
Disease associations
OMIM: gene MIM:611792 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
4 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST007005_2 | Logical memory (immediate recall) in normal cognition | 1.000000e-07 |
| GCST010397_101 | Gut microbiota (bacterial taxa, rank normal transformation method) | 1.000000e-07 |
| GCST010397_94 | Gut microbiota (bacterial taxa, rank normal transformation method) | 3.000000e-08 |
| GCST012332_61 | Multisite chronic pain | 1.000000e-11 |
EFO canonical traits (3, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004874 | memory performance |
| EFO:0007874 | gut microbiome measurement |
| EFO:0010100 | multisite chronic pain |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
15 total (human), top 15 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| methylmercuric chloride | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| bisphenol A | decreases methylation | 1 |
| deoxynivalenol | increases expression | 1 |
| sodium arsenite | increases expression | 1 |
| cylindrospermopsin | increases expression | 1 |
| 2-palmitoylglycerol | increases expression | 1 |
| abrine | increases expression | 1 |
| Leflunomide | increases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Silicon Dioxide | increases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Cyclosporine | increases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
| Antirheumatic Agents | increases expression | 1 |
Cellosaurus cell lines
4 cell lines: 4 cancer cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_TY57 | HAP1 ZCCHC4 (-) 1 | Cancer cell line | Male |
| CVCL_TY58 | HAP1 ZCCHC4 (-) 2 | Cancer cell line | Male |
| CVCL_TY59 | HAP1 ZCCHC4 (-) 3 | Cancer cell line | Male |
| CVCL_TY60 | HAP1 ZCCHC4 (-) 4 | Cancer cell line | Male |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.